ID   ZEC-118
AC   CVCL_VT83
DR   CCRID; 4201PAT-CCTCC00895
DR   Wikidata; Q98136460
RX   Patent=CN106047814A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201694.
CC   Population: Chinese.
CC   Doubling time: ~52 hours (Patent=CN106047814A).
ST   Source(s): Patent=CN106047814A
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,19
ST   D13S317: 10,11
ST   D16S539: 9
ST   D18S51: 15,21
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D2S1338: 18,20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D6S1043: 17,18
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 23,25
ST   Penta D: 8,13
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
RX   Patent=CN106047814A;
RA   Su D., Mao W.-M., Jiang Y.-H., Ying L.-S., Wu J.-Z.;
RT   "Esophageal cancer cell line and application thereof.";
RL   Patent number CN106047814A, 26-Oct-2016.
//